Bellevue Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $24.2M | Hold |
|
|||||
|
2024
Q3 | $32.2M | Sell |
|
|||||
|
2024
Q2 | $48.5M | Sell |
|
|||||
|
2024
Q1 | $83.7M | Buy |
|
|||||
|
2023
Q4 | $76.1M | Hold |
|
|||||
|
2023
Q3 | $72.3M | Buy |
|
|||||
|
2023
Q2 | $146M | Buy |
|
|||||
|
2023
Q1 | $130M | Buy |
|
|||||
|
2022
Q4 | $113M | Sell |
|
|||||
|
2022
Q3 | $116M | Sell |
|
|||||
|
2022
Q2 | $96M | Sell |
|
|||||
|
2022
Q1 | $101M | Sell |
|
|||||
|
2021
Q4 | $137M | Buy |
|
|||||
|
2021
Q3 | $142M | Buy |
|
|||||
|
2021
Q2 | $134M | Buy |
|
|||||
|
2021
Q1 | $136M | Buy |
|
|||||
|
2020
Q4 | $136M | Sell |
|
|||||
|
2020
Q3 | $96.5M | Buy |
|
|||||
|
2020
Q2 | $58.9M | Sell |
|
|||||
|
2020
Q1 | $40.7M | Buy |
|
|||||
|
2019
Q4 | $94.5M | Buy |
|
|||||
|
2019
Q3 | $183M | Sell |
|
|||||
|
2019
Q2 | $242M | Buy |
|
|||||
|
2019
Q1 | $2.59M | Buy |
|
|||||
|
2018
Q4 | $1.01M | Sell |
|
|||||
|
2018
Q3 | $1.58M | Sell |
|
|||||
|
2018
Q2 | $1.89M | Sell |
|
|||||
|
2018
Q1 | $2M | Sell |
|
|||||
|
2017
Q4 | $2.08M | Buy |
|